SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-003083
Filing Date
2019-01-07
Accepted
2019-01-07 07:14:06
Documents
6
Period of Report
2019-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d674169d8k.htm 8-K 32627
2 EX-2.1 d674169dex21.htm EX-2.1 453490
3 EX-10.1 d674169dex101.htm EX-10.1 69219
4 EX-99.1 d674169dex991.htm EX-99.1 34461
5 GRAPHIC g674169n1.jpg GRAPHIC 10970
6 GRAPHIC g674169n2.jpg GRAPHIC 4783
  Complete submission text file 0001193125-19-003083.txt   612912
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 19512161
SIC: 2834 Pharmaceutical Preparations